26^th Global Ophthalmologists Annual Meeting

Dry Eye Disease: Emerging Therapies

Dry eye disease (DED) is evolving with promising therapies aimed at alleviating symptoms and improving ocular surface health. Emerging treatments include novel lubricants, such as lipid-based formulations, which stabilize tear film and enhance moisture retention. Anti-inflammatory agents target underlying immune responses that contribute to chronic dryness and discomfort. Advanced technologies like intense pulsed light therapy and thermal pulsation systems offer non-invasive approaches to improve Meibomian gland function and alleviate evaporative dry eye. Furthermore, regenerative therapies utilizing growth factors and stem cells show potential for restoring damaged ocular tissues and promoting natural tear production. These innovations signal a hopeful future for managing DED more effectively and enhancing patients' quality of life.